株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

米国の病院の止血診断検査市場における戦略

2016-2020 U.S. Hospital Hemostasis Diagnostics Market

発行 Venture Planning Group 商品コード 319111
出版日 ページ情報 英文 411 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。

Local License: 同一事業所内

Back to Top
米国の病院の止血診断検査市場における戦略 2016-2020 U.S. Hospital Hemostasis Diagnostics Market
出版日: ページ情報: 英文 411 Pages
概要

当レポートでは、米国の病院の止血診断検査市場について調査分析し、世界市場と技術の概要、市場の現状と将来予測のほか、主な製品開発の機会、市場参入戦略、主要企業の評価などについて、体系的な情報を提供しています。

世界市場と技術の概要

  • 主な定期的・特殊凝固検査
    • イントロダクション
    • APTT(活性化部分トロンボプラスチン時間)
    • α2抗プラズミン物質
    • 抗トロンビンIII
    • 出血時間
    • D-ダイマー
    • エタノール凝固テスト
    • ユーグロブリン溶解
    • 因子測定
    • フィブリン分解物
    • フィブリノゲン(線維素原)
    • ヘパリン
    • ヒルジン
    • 凝血能亢進および血栓症
    • リポタンパク質A
    • プラスミン
    • プラスミノゲン
    • プラスミノゲン活性化因子阻害因子(PAI)
    • 血小板機能検査
    • 血小板凝集
    • プロテインC・プロテインS
    • プロトロンビンフラグメント1.2
    • プロトロンビン時間(PT)
    • レプチラーセ時間
    • トロンビン時間
    • t-PA(組織型プラスミノゲン活性化因子)
    • フォン・ヴィレブランド因子
  • 検査装置のレビュー
  • 主要な体外診断検査技術と潜在的な用途
    • 発色基質
    • モノクローナル抗体とポリクローナル抗体
    • イムノアッセイ(免疫測定法)
    • マイクロコンピューター
    • オートメーション
    • ロボット工学
    • DNAプローブ
    • 人工知能
    • ドライケミストリー
    • バイオセンサー
  • 世界市場の概要
    • ビジネス環境
    • 市場構造
    • 市場規模・成長率
    • POC検査市場

米国

  • エグゼクティブサマリー
  • ビジネス環境
  • 市場構造
  • 市場規模・成長率、主要サプライヤー

主な製品開発の機会

分散型検査製品の設計基準

代替的な市場普及戦略

  • 内部開発
  • 共同事業協定
  • 大学との契約
  • 分散型検査市場の流通戦略
    • マーケティングのアプローチ
    • 製品の複雑性
    • 顧客の選好
    • 既存のサプライヤー
    • 新興のサプライヤー
    • 主な流通業者のタイプ
    • 市場セグメント

潜在的な市場参入障壁とリスク

  • 市場の成熟
  • コスト抑制
  • 競合
  • 技術面での優位性と限界
  • 特許権保護
  • 規制上の制約
  • 分散型検査市場の課題

競合企業の評価

  • Abbott
  • American Diagnostica
  • Avocet Medical
  • Axis-Shield
  • Beckman Coulter
  • Becton Dickinson
  • Bio/Data Corporation
  • Biosite
  • Chrono-Log
  • Corgenix Medical
  • Diagnostica Stago
  • Helena Laboratories
  • HYPEN BioMed
  • Instrumentation Laboratory
  • ITC
  • Nanogen
  • Roche
  • Siemens
  • Sienco
  • Sysmex
  • Thermo Fischer
  • Trinity Biotech
  • ZyCare

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPHS18355

This new report from VPGMarketResearch.com contains 411 pages, 28 tables, and presents a comprehensive analysis of the US hospital hemostasis diagnostic testing market, including: 

  • Major issues pertaining to the US hospital coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. 
  • Volume and sales forecasts for 40 coagulation procedures performed in US hospitals, including typical coagulation daily work loads. 
  • Review of current instrumentation technologies, and a feature comparison of leading analyzers. 
  • Reagent and instrument sales forecasts. 
  • Sales and market shares of leading reagent and instrument suppliers. 
  • Review of coagulation technologies and their potential market applications. 
  • Major opportunities for new coagulation instruments and consumables. 
  • Profiles of  major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. 
  • Business opportunities and strategic recommendations for instrument and reagent suppliers. 

         Contains 411 pages and 28 tables

Table of Contents

Worldwide Market and Technology Overview

  • A. Major Routine and Special Coagulation Tests
    • 1. Introduction
    • 2. Activated Partial Thromboplastin Time (APTT)
    • 3. Alpha-2 Antiplasmin
    • 4. Antithrombin III
    • 5. Bleeding Time
    • 6. D-Dimer
    • 7. Ethanol Flocculation Test
    • 8. Euglobulin Lysis
    • 9. Factor Assays
      • a. Introduction
      • b. Factor II
      • c. Factor V/Factor V Leiden
      • d. Factor VII
      • e. Factor VIII
      • f. Factor IX
      • g. Factor IXa
      • h. Factor X (Stuart Factor)
      • i. Factor Xa
      • j. Factor XI
      • k. Factor XII
      • l. Factor XIII
    • 10. Fibrin Degradation Products
    • 11. Fibrinogen
    • 12. Heparin
    • 13. Hirudin
    • 14. Hypercoagulability and Thrombosis
    • 15. Lipoprotein a
    • 16. Plasmin
    • 17. Plasminogen
    • 18. Plasminogen Activator Inhibitor (PAI)
    • 19. Platelet Function Tests
    • 20. Platelet Aggregation
    • 21. Proteins C and S
    • 22. Prothrombin Fragment 1.2
    • 23. Prothrombin Time (PT)
    • 24. Reptilase Time
    • 25. Thrombin Time
    • 26. Tissue-Type Plasminogen Activator (t-PA)
    • 27. Von Willebrand's Factor
  • B. Instrumentation Review
    • Introduction
    • Benk Hemolab
    • Benk TRT Thrombotimer
    • Bio/Data MCA 310
    • Bio/Data MCA 210
    • Bio/Data PAP-4C D/4D/4C
    • Cardiovascular Diagnostics COAG
    • Diagnostica Stago STA Compact
    • Diagnostica Stago STA-R
    • Diagnostica Stago Star 4/8
    • Helena Laboratories Cascade 480
    • Helena Laboratories Cascade M
    • Helena Laboratories PACKS-4
    • Helena THOR
    • Instrumentation Laboratory ACL 100 and 1000 series
    • Instrumentation Laboratory ACL6000
    • Instrumentation Laboratory ACL7000
    • Instrumentation Laboratory ACL9000
    • Instrumentation Laboratory Electra 1000C
    • Instrumentation Laboratory Electra 1400C
    • Instrumentation Laboratory Electra 1600/C
    • Instrumentation Laboratory Electra 1800C
    • Instrumentation Laboratory Futura
    • ITC Hemochron 8000
    • Roche Diagnostics CoaguChek
    • Siemens BCS
    • Siemens BCT
    • Siemens BF II/Fibrintimer Series
    • Sysmex CA-50
    • Sysmex CA-500
    • Sysmex CA-1500
    • Sysmex CA-5000/CA-1000
    • Sysmex CA-6000
    • Sysmex CA-7000
    • Teco Coatron II/Jr./AccuStasis 5000
    • Trinity Biotech Amax CS190
    • Trinity Biotech Amax CS400
    • Trinity Biotech Coag-A-Mate Max
    • Trinity Biotech KC 40, 4A, 1A Series
    • Trinity Biotech MDA 180
    • Trinity Biotech Coag-A-Mate MTX
    • Trinity Biotech Coag-A-Mate RA4
    • Trinity Biotech Coag-A-Mate XC/Plus
    • Trinity Biotech Coag-A-Mate XM
  • C. Major in Vitro Diagnostic Technologies and Their Potential Applications
    • 1. Chromogenic Substrates
    • 2. Monoclonal and Polyclonal Antibodies
    • 3. Immunoassays
      • a. Applications
      • b. Technological Principle
      • c. Enzyme Immunoassays (EIA)
        • Overview
        • ELISA
        • EMIT
        • Dot Immunobinding Assays
        • Capillary Immunoassays
        • Enzyme Amplification
        • Electrochemical Immunoassay
      • d. Fluorescent Immunoassays
        • Fluorescence Polarization
        • Time-Resolved Pulse Fluorescence
        • Fluorescence Lifetime
      • e. Latex Agglutination
      • f. Immunoprecipitation
    • 4. Microcomputers
    • 5. Automation
    • 6. Robotics
    • 7. DNA Probes
      • a. Overview
      • b. Amplification Methods
        • PCR
        • Ligase Chain Reaction
        • Branched DNA
        • Q-Beta Replicase
        • NASBA
        • SDA
        • 3 SR
        • HPA
        • Two-Tiered System
        • LAT
    • 8. Artificial Intelligence
    • 9. Dry Chemistry
    • 10. Biosensors

USA

  • A. Executive Summary
  • B. Business Environment
    • 1. Health Care Expenditures
    • 2. Cost Consciousness
    • 3. Industry Consolidation
    • 4. Managed Care
    • 5. Hospitals
    • 6. Admissions
    • 7. Length of Stay
    • 8. Industry Diversification
    • 9. Physician Demographics
    • 10. Population Aging
      • a. Chronic Illnesses
      • b. Disease Incidence
      • c. Susceptibility to Iatrogenesis
      • d. Multiple Illness Cases
    • 11. Laboratory Regulations
  • C. Market Structure
    • 1. Centralized Testing
      • a. Hospitals
      • b. Commercial laboratories
    • 2. Decentralized Testing
      • a. Physician Offices/Group Practices
      • b. Point-of-Care Testing
      • c. Home/Self Testing
      • d. Other Decentralized Testing Locations
  • D. Market Size, Growth And Major Suppliers

Major Product Development Opportunities

Design Criteria For Decentralized Testing Products

Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types Of Distributors
    • 7. Market Segmentation

Potential Market Entry Barriers And Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge And Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

Competitive Assessments

  • Abbott
  • American Diagnostica
  • Avocet Medical
  • Axis-Shield
  • Beckman Coulter
  • Becton Dickinson
  • Bio/Data Corporation
  • Biosite
  • Chrono-Log
  • Corgenix Medical
  • Diagnostica Stago
  • Helena Laboratories
  • HYPEN BioMed
  • Instrumentation Laboratory
  • ITC
  • Nanogen
  • Roche
  • Siemens
  • Sienco
  • Sysmex
  • Thermo Fischer
  • Trinity Biotech
  • ZyCare

List of Tables

  • Major Companies Developing or Marketing Activated Clotting Time Tests
  • Major Companies Developing or Marketing APTT Tests
  • Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
  • Major Companies Developing or Marketing Antithrombin III Tests
  • Major Companies Developing or Marketing Bleeding Time Tests
  • Major Companies Developing or Marketing D-dimer Tests
  • Major Companies Developing or Marketing Factor Assays
  • Major Companies Developing or Marketing Fibrin Degradation Product Tests
  • Major Companies Developing or Marketing Fibrinogen Tests
  • Major Companies Developing or Marketing Heparin Tests
  • Major Companies Developing or Marketing Plasmin Tests
  • Major Companies Developing or Marketing Plasminogen Tests
  • Major Companies Developing or Marketing Plasminogen Activator Inhibitor Tests
  • Major Companies Developing or Marketing Platelet Aggregation Tests
  • Major Companies Developing or Marketing Protein C Tests
  • Major Companies Developing or Marketing Protein S Tests
  • Major Companies Developing or Marketing PT Tests
  • Major Companies Developing or Marketing Thrombin Time Tests
  • Major Companies Developing or Marketing TPA Tests
  • Major Companies Developing or Marketing Von Willebrand's Factor Tests
  • Executive Summary Table: U.S.A., Hospital Coagulation Diagnostics Market By Product Category
  • U.S.A., Hospital Laboratories Performing Coagulation Tests By Bed Size
  • U.S.A., Hospital Laboratories Average Daily Test Volume
  • U.S.A., Hospital Laboratories Coagulation Test Volume by Assay U.S.A., Major Suppliers of Coagulation Reagents, Estimated Sales and Market Shares
  • U.S.A., Major Suppliers of Coagulation Analyzers, Estimated Sales and Market Shares
  • U.S.A., Coagulation Diagnostics Market By Product Category
  • U.S.A., Major Suppliers of Coagulation Diagnostic Products, Estimated Sales and Market Shares
Back to Top